IBDEI36L ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,50793,1,4,0)
;;=4^D51.1
;;^UTILITY(U,$J,358.3,50793,2)
;;=^5002285
;;^UTILITY(U,$J,358.3,50794,0)
;;=D51.9^^193^2497^197
;;^UTILITY(U,$J,358.3,50794,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50794,1,3,0)
;;=3^Vitamin B12 Deficiency Anemia,Unspec
;;^UTILITY(U,$J,358.3,50794,1,4,0)
;;=4^D51.9
;;^UTILITY(U,$J,358.3,50794,2)
;;=^5002289
;;^UTILITY(U,$J,358.3,50795,0)
;;=D68.0^^193^2497^199
;;^UTILITY(U,$J,358.3,50795,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50795,1,3,0)
;;=3^Von Willebrand's Disease
;;^UTILITY(U,$J,358.3,50795,1,4,0)
;;=4^D68.0
;;^UTILITY(U,$J,358.3,50795,2)
;;=^127267
;;^UTILITY(U,$J,358.3,50796,0)
;;=C88.0^^193^2497^200
;;^UTILITY(U,$J,358.3,50796,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50796,1,3,0)
;;=3^Waldenstrom Macroglobulinemia
;;^UTILITY(U,$J,358.3,50796,1,4,0)
;;=4^C88.0
;;^UTILITY(U,$J,358.3,50796,2)
;;=^5001748
;;^UTILITY(U,$J,358.3,50797,0)
;;=C91.02^^193^2497^3
;;^UTILITY(U,$J,358.3,50797,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50797,1,3,0)
;;=3^Acute Lymphoblastic Leukemia,In Relapse
;;^UTILITY(U,$J,358.3,50797,1,4,0)
;;=4^C91.02
;;^UTILITY(U,$J,358.3,50797,2)
;;=^5001764
;;^UTILITY(U,$J,358.3,50798,0)
;;=C92.02^^193^2497^6
;;^UTILITY(U,$J,358.3,50798,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50798,1,3,0)
;;=3^Acute Myeloblastic Leukemia,In Relapse
;;^UTILITY(U,$J,358.3,50798,1,4,0)
;;=4^C92.02
;;^UTILITY(U,$J,358.3,50798,2)
;;=^5001791
;;^UTILITY(U,$J,358.3,50799,0)
;;=D09.3^^193^2497^46
;;^UTILITY(U,$J,358.3,50799,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50799,1,3,0)
;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
;;^UTILITY(U,$J,358.3,50799,1,4,0)
;;=4^D09.3
;;^UTILITY(U,$J,358.3,50799,2)
;;=^5001955
;;^UTILITY(U,$J,358.3,50800,0)
;;=C22.0^^193^2497^87
;;^UTILITY(U,$J,358.3,50800,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50800,1,3,0)
;;=3^Hepatocellular Carcinoma
;;^UTILITY(U,$J,358.3,50800,1,4,0)
;;=4^C22.0
;;^UTILITY(U,$J,358.3,50800,2)
;;=^5000933
;;^UTILITY(U,$J,358.3,50801,0)
;;=C24.9^^193^2497^114
;;^UTILITY(U,$J,358.3,50801,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50801,1,3,0)
;;=3^Malig Neop Biliary Tract,Unspec
;;^UTILITY(U,$J,358.3,50801,1,4,0)
;;=4^C24.9
;;^UTILITY(U,$J,358.3,50801,2)
;;=^5000942
;;^UTILITY(U,$J,358.3,50802,0)
;;=C50.922^^193^2497^138
;;^UTILITY(U,$J,358.3,50802,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50802,1,3,0)
;;=3^Malig Neop Left Male Breast,Unspec Site
;;^UTILITY(U,$J,358.3,50802,1,4,0)
;;=4^C50.922
;;^UTILITY(U,$J,358.3,50802,2)
;;=^5133340
;;^UTILITY(U,$J,358.3,50803,0)
;;=C34.91^^193^2497^156
;;^UTILITY(U,$J,358.3,50803,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50803,1,3,0)
;;=3^Malig Neop Right Bronchus/Lung,Unspec Part
;;^UTILITY(U,$J,358.3,50803,1,4,0)
;;=4^C34.91
;;^UTILITY(U,$J,358.3,50803,2)
;;=^5000967
;;^UTILITY(U,$J,358.3,50804,0)
;;=C50.921^^193^2497^160
;;^UTILITY(U,$J,358.3,50804,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50804,1,3,0)
;;=3^Malig Neop Right Male Breast,Unspec Site
;;^UTILITY(U,$J,358.3,50804,1,4,0)
;;=4^C50.921
;;^UTILITY(U,$J,358.3,50804,2)
;;=^5001198
;;^UTILITY(U,$J,358.3,50805,0)
;;=C90.02^^193^2497^172
;;^UTILITY(U,$J,358.3,50805,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50805,1,3,0)
;;=3^Multiple Myeloma,In Relapse
;;^UTILITY(U,$J,358.3,50805,1,4,0)
;;=4^C90.02
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI36L 3781 printed Oct 16, 2024@18:43:35 Page 2
IBDEI36L ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,50793,1,4,0)
+2 ;;=4^D51.1
+3 ;;^UTILITY(U,$J,358.3,50793,2)
+4 ;;=^5002285
+5 ;;^UTILITY(U,$J,358.3,50794,0)
+6 ;;=D51.9^^193^2497^197
+7 ;;^UTILITY(U,$J,358.3,50794,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,50794,1,3,0)
+10 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
+11 ;;^UTILITY(U,$J,358.3,50794,1,4,0)
+12 ;;=4^D51.9
+13 ;;^UTILITY(U,$J,358.3,50794,2)
+14 ;;=^5002289
+15 ;;^UTILITY(U,$J,358.3,50795,0)
+16 ;;=D68.0^^193^2497^199
+17 ;;^UTILITY(U,$J,358.3,50795,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,50795,1,3,0)
+20 ;;=3^Von Willebrand's Disease
+21 ;;^UTILITY(U,$J,358.3,50795,1,4,0)
+22 ;;=4^D68.0
+23 ;;^UTILITY(U,$J,358.3,50795,2)
+24 ;;=^127267
+25 ;;^UTILITY(U,$J,358.3,50796,0)
+26 ;;=C88.0^^193^2497^200
+27 ;;^UTILITY(U,$J,358.3,50796,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,50796,1,3,0)
+30 ;;=3^Waldenstrom Macroglobulinemia
+31 ;;^UTILITY(U,$J,358.3,50796,1,4,0)
+32 ;;=4^C88.0
+33 ;;^UTILITY(U,$J,358.3,50796,2)
+34 ;;=^5001748
+35 ;;^UTILITY(U,$J,358.3,50797,0)
+36 ;;=C91.02^^193^2497^3
+37 ;;^UTILITY(U,$J,358.3,50797,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,50797,1,3,0)
+40 ;;=3^Acute Lymphoblastic Leukemia,In Relapse
+41 ;;^UTILITY(U,$J,358.3,50797,1,4,0)
+42 ;;=4^C91.02
+43 ;;^UTILITY(U,$J,358.3,50797,2)
+44 ;;=^5001764
+45 ;;^UTILITY(U,$J,358.3,50798,0)
+46 ;;=C92.02^^193^2497^6
+47 ;;^UTILITY(U,$J,358.3,50798,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,50798,1,3,0)
+50 ;;=3^Acute Myeloblastic Leukemia,In Relapse
+51 ;;^UTILITY(U,$J,358.3,50798,1,4,0)
+52 ;;=4^C92.02
+53 ;;^UTILITY(U,$J,358.3,50798,2)
+54 ;;=^5001791
+55 ;;^UTILITY(U,$J,358.3,50799,0)
+56 ;;=D09.3^^193^2497^46
+57 ;;^UTILITY(U,$J,358.3,50799,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,50799,1,3,0)
+60 ;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
+61 ;;^UTILITY(U,$J,358.3,50799,1,4,0)
+62 ;;=4^D09.3
+63 ;;^UTILITY(U,$J,358.3,50799,2)
+64 ;;=^5001955
+65 ;;^UTILITY(U,$J,358.3,50800,0)
+66 ;;=C22.0^^193^2497^87
+67 ;;^UTILITY(U,$J,358.3,50800,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,50800,1,3,0)
+70 ;;=3^Hepatocellular Carcinoma
+71 ;;^UTILITY(U,$J,358.3,50800,1,4,0)
+72 ;;=4^C22.0
+73 ;;^UTILITY(U,$J,358.3,50800,2)
+74 ;;=^5000933
+75 ;;^UTILITY(U,$J,358.3,50801,0)
+76 ;;=C24.9^^193^2497^114
+77 ;;^UTILITY(U,$J,358.3,50801,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,50801,1,3,0)
+80 ;;=3^Malig Neop Biliary Tract,Unspec
+81 ;;^UTILITY(U,$J,358.3,50801,1,4,0)
+82 ;;=4^C24.9
+83 ;;^UTILITY(U,$J,358.3,50801,2)
+84 ;;=^5000942
+85 ;;^UTILITY(U,$J,358.3,50802,0)
+86 ;;=C50.922^^193^2497^138
+87 ;;^UTILITY(U,$J,358.3,50802,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,50802,1,3,0)
+90 ;;=3^Malig Neop Left Male Breast,Unspec Site
+91 ;;^UTILITY(U,$J,358.3,50802,1,4,0)
+92 ;;=4^C50.922
+93 ;;^UTILITY(U,$J,358.3,50802,2)
+94 ;;=^5133340
+95 ;;^UTILITY(U,$J,358.3,50803,0)
+96 ;;=C34.91^^193^2497^156
+97 ;;^UTILITY(U,$J,358.3,50803,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,50803,1,3,0)
+100 ;;=3^Malig Neop Right Bronchus/Lung,Unspec Part
+101 ;;^UTILITY(U,$J,358.3,50803,1,4,0)
+102 ;;=4^C34.91
+103 ;;^UTILITY(U,$J,358.3,50803,2)
+104 ;;=^5000967
+105 ;;^UTILITY(U,$J,358.3,50804,0)
+106 ;;=C50.921^^193^2497^160
+107 ;;^UTILITY(U,$J,358.3,50804,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,50804,1,3,0)
+110 ;;=3^Malig Neop Right Male Breast,Unspec Site
+111 ;;^UTILITY(U,$J,358.3,50804,1,4,0)
+112 ;;=4^C50.921
+113 ;;^UTILITY(U,$J,358.3,50804,2)
+114 ;;=^5001198
+115 ;;^UTILITY(U,$J,358.3,50805,0)
+116 ;;=C90.02^^193^2497^172
+117 ;;^UTILITY(U,$J,358.3,50805,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,50805,1,3,0)
+120 ;;=3^Multiple Myeloma,In Relapse
+121 ;;^UTILITY(U,$J,358.3,50805,1,4,0)
+122 ;;=4^C90.02
